Warren Remedies Private Limited

Warren Remedies Private Limited - pharma in Aurangabad, Maharashtra, India. FY 2026 financials & compliance.
CIN U24304MH2022PTC384184 Incorporated 07 June 2022 ROC Mumbai HQ Aurangabad, Maharashtra, India
Active Private Limited Company pharma
Revenue · FY 2025
₹98.74 Cr
▲ 2320% YoY
Net loss · FY 2025
₹37.77 Cr
Net margin -38.2%
EBITDA · FY 2025
-₹8.33 Cr
EBITDA margin -8.4%
Authorised capital
₹30 Cr
Registered with MCA
Paid-up capital
₹15 Cr
Issued & subscribed
Open charges
₹239 Cr
Secured borrowings
Company age
4 yrs
Est. 2022
Employees · EPFO
405
Provident fund records

About Warren Remedies Private Limited

Data last updated:

Warren Remedies Private Limited is a private limited company based in Aurangabad, Maharashtra, India, a subsidiary of Indoco Remedies Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 June 2022.

Its director Suresh G Kare is #1,673 among India's richest people (2026).

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2022PTC384184. Its GSTIN is 27AADCW2799L1ZK (Maharashtra). The company holds 6 GST registrations, all of them active.

The company has an authorised share capital of ₹30 Cr and a paid-up capital of ₹15 Cr. It is led by directors including Amulya Ranjan Nayak (Whole-Time Director) and Sundeep Vasant Bambolkar.

Its last annual general meeting (AGM) was held on 10 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Aurangabad, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹98.74 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹37.77 Cr (net margin -38.2%) and EBITDA of -₹8.33 Cr (EBITDA margin -8.4%).

The company has about 405 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹239 Cr on record. The company has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹10 Cr; the latest was in August 2022. Its 10 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Vineet Life Sciences Limited with revenue of ₹101.85 Cr.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website warrenremedies.com.

Company details

CIN U24304MH2022PTC384184
Registration Number 384184
Incorporation Date 07 June 2022
ROC Mumbai
Listing Status Unlisted
Company Status Active
Parent Company Indoco Remedies Limited
Compliance Status Active Compliant

Recognitions & Rankings of Warren Remedies

India's Richest People 2026 edition · 1 director · Source: Hurun India

Contact details

Warren Remedies Private Limited's registered office is in Aurangabad, Maharashtra. Its website is warrenremedies.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No – 17 Auric Shendra, Sector No – 13 Shendra MIDC, Aurangabad, Maharashtra, India – 431154
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Warren Remedies Private Limited, buy the company report.

Comprehensive company report
Warren Remedies Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Warren Remedies is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Warren Remedies Private Limited, buy the company report.

Financials of Warren Remedies Private Limited

FY 2025 filings available

Warren Remedies Private Limited reported revenue of ₹98.74 Cr (up 2320% YoY) for FY 2025.

Revenue · FY 2025
₹98.74 Cr ▲ 2320%
Net loss · FY 2025
₹37.77 Cr margin -38.2%
EBITDA · FY 2025
-₹8.33 Cr margin -8.4%

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹8.33 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹37.77 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23
Profitability
EBITDA Margin-8.4%
Net Profit Margin-38.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Warren Remedies Private Limited, buy the company report.

Board of directors of Warren Remedies Private Limited

Warren Remedies has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sundeep Vasant BambolkarDirector07 Jun 20224 Years 5 MonthsCurrent
Aditi Milind PanandikarDirector07 Jun 20224 Years 5 MonthsCurrent
Ulhas Anant JoshiDirector01 Apr 20242 Years 7 MonthsCurrent
Amulya Ranjan NayakWhole-Time Director14 May 20242 Years 6 MonthsCurrent
Suresh Govind KareAdditional Director05 Nov 20251 Years 0 MonthsCurrent

Peer comparison

Warren Remedies Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Vineet Life Sciences Limited₹101.85 Cr (FY 2024)48.0%Hyderabad, Telangana, India
Sna Healthcare Private Limited₹101.57 Cr (FY 2025)17.0%Mumbai, Maharashtra, India
Sarv Bio Labs Private Limited₹101.4 Cr (FY 2024)-10.0%Himachal Pradesh, India
Valens Molecules Private Limited₹100.32 Cr (FY 2025)0.0%Hyderabad, Telangana, India
Ketul Chem Private Limited₹98.92 Cr (FY 2025)12.0%Mumbai, Maharashtra, India
Warren Remedies Private Limitedthis company₹98.74 Cr (FY 2025)-₹37.77 Cr-38.2%2320.0%405Aurangabad, Maharashtra, India
Benova Labs Private Limited₹98.59 Cr (FY 2025)-6.0%Hyderabad, Telangana, India
Teena Labs Limited₹96.94 Cr (FY 2024)-46.0%Hyderabad, Telangana, India
B G P Healthcare Private Limited₹95.66 Cr (FY 2025)-1.0%Ankleshwar, Gujarat, India
Virupaksha Laboratories Private Limited₹94.74 Cr (FY 2024)12.0%Hyderabad, Telangana, India
Aurore Pharmaceuticals Private Limited₹94.5 Cr (FY 2025)1.0%Hyderabad, Telangana, India

To see the full peer comparison of Warren Remedies Private Limited, buy the company report.

Auditor

Warren Remedies Private Limited is audited by D. S. Mahambre & Co for the financial year 2023.

Auditor firmFinancial yearFirm registration number
D. S. Mahambre & CoFY 2023105754W

Shareholding

The shareholding of Warren Remedies Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Warren Remedies Private Limited, buy the company report.

Charges & borrowings

Open charges
₹239 Cr
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹150.00 Cr
Standard Chartered Bank₹89.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
09 Jul 2024100953748Hdfc Bank Limited₹25 CrOpen
08 Jul 2024100952896Hdfc Bank Limited₹125 CrOpen
19 Oct 2023100802809Standard Chartered Bank₹89 CrOpen

To see the full charge records of Warren Remedies Private Limited, buy the company report.

Total charge records: 3 View all charges

Deals & funding

Warren Remedies Private Limited has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹10 Cr; the latest was in August 2022.

Total deals
2
Rights issue
1
Funding round
1
Disclosed funding
₹10 Cr

Deals on record (2 of 2)

WhenDealAmountParties
Aug 2022Rights issue₹4.99 CrInvestors: Indoco Remedies Limited
Aug 2022Funding round₹10 CrInvestors: Indoco Remedies Limited

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Warren Remedies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Warren Remedies Private Limited has a workforce of 405 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
405
Active EPFO establishments
1
Employee growth
234.7%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27405
FY 2025-26
FY 2024-25
FY 2023-24

To see the full employee and EPFO history of Warren Remedies Private Limited, buy the company report.

GST

Warren Remedies has 6 GST registrations: 6 active. The first 4 active GSTINs are listed below.

Total GSTINs
6
Active
6
GSTINStateStatusRegistered on
27AADCW2799L1ZKMaharashtraActive09 Aug 2022
27AADCW2799L2ZJMaharashtraActive16 Sep 2024
29AADCW2799L1ZGKarnatakaActive07 Feb 2024
36AADCW2799L1ZLTelanganaActive13 Feb 2024

To see the full GST registrations and return filing status of Warren Remedies Private Limited, buy the company report.

Recent activity

Warren Remedies Private Limited has 9 board changes on record since 2022: 6 appointments and 3 cessations. The latest: Suresh Govind Kare was appointed as Additional Director on 05 Nov 2025.

Appointed
Suresh Govind Kare was appointed as Additional Director.
AGM
Warren Remedies Private Limited last Annual general meeting of members was held on 10 Sep 2025 as per latest MCA records.
Filing
Warren Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Hdfc Bank Limited of Rs. 125.00 Cr registered on 08 Jul 2024 with Charge ID 100952896 was modified on 25 Mar 2025.
Ceased
Ulhas Anant Joshi ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 25.00 Cr with Charge ID 100953748 was registered on 09 Jul 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 125.00 Cr with Charge ID 100952896 was registered on 08 Jul 2024.
Charges
A charge with Standard Chartered Bank of Rs. 89.00 Cr registered on 19 Oct 2023 with Charge ID 100802809 was modified on 21 Jun 2024.
Appointed
Amulya Ranjan Nayak was appointed as Whole-Time Director.
Appointed
Ulhas Anant Joshi was appointed as Director.
Charges
A charge with Standard Chartered Bank amounted to Rs. 89.00 Cr with Charge ID 100802809 was registered on 19 Oct 2023.
Appointed
Jayshankar Menon was appointed as Company Secretary.

5 earlier events are in the company report.

Frequently asked questions

Warren Remedies is an active private limited company based in Aurangabad, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 June 2022 (4+ years old) and is registered under CIN U24304MH2022PTC384184.

Warren Remedies has 5 current directors:

The latest financial statements of Warren Remedies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 10 September 2025. Year-wise statements from FY 2023 are in the company report.

The GSTIN of Warren Remedies is 27AADCW2799L1ZK, registered in Maharashtra. The company has 6 GST registrations in all, of which 6 are active. Other active GSTINs include 27AADCW2799L2ZJ (Maharashtra), 29AADCW2799L1ZG (Karnataka), 36AADCW2799L1ZL (Telangana).

The CIN (Corporate Identification Number) of Warren Remedies is U24304MH2022PTC384184. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Warren Remedies was incorporated on 07 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.

Warren Remedies has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹10 Cr; the latest was in August 2022.

The peers of Warren Remedies by revenue are Vineet Life Sciences Limited, Sna Healthcare Private Limited, Sarv Bio Labs Private Limited, Valens Molecules Private Limited, Ketul Chem Private Limited and 5 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Suresh Govind Kare was appointed as Additional Director on 05 Nov 2025. Ulhas Anant Joshi ceased to be Additional Director on 23 Sep 2024. Amulya Ranjan Nayak was appointed as Whole-Time Director on 14 May 2024. Warren Remedies has 9 board changes on record in total.

Warren Remedies can be reached through the website warrenremedies.com. Its registered office is in Aurangabad, Maharashtra, India.

The registered office of Warren Remedies is at Plot No – 17 Auric Shendra, Sector No – 13 Shendra MIDC, Aurangabad, Maharashtra, India – 431154.